[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR20090048899A - Method of preparing intermediates of penem antibiotics - Google Patents

Method of preparing intermediates of penem antibiotics Download PDF

Info

Publication number
KR20090048899A
KR20090048899A KR1020070114994A KR20070114994A KR20090048899A KR 20090048899 A KR20090048899 A KR 20090048899A KR 1020070114994 A KR1020070114994 A KR 1020070114994A KR 20070114994 A KR20070114994 A KR 20070114994A KR 20090048899 A KR20090048899 A KR 20090048899A
Authority
KR
South Korea
Prior art keywords
formula
group
compound
acetate
butyl acetate
Prior art date
Application number
KR1020070114994A
Other languages
Korean (ko)
Inventor
송충의
한상섭
Original Assignee
성균관대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성균관대학교산학협력단 filed Critical 성균관대학교산학협력단
Priority to KR1020070114994A priority Critical patent/KR20090048899A/en
Priority to PCT/KR2008/006182 priority patent/WO2009064078A1/en
Publication of KR20090048899A publication Critical patent/KR20090048899A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/18Oxygen atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46Ruthenium, rhodium, osmium or iridium
    • B01J23/464Rhodium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

본 발명은 카바폐넴계 항생제의 핵심 중간체인 비사이클릭 케토에스테르 화합물(bicyclic keto ester)을 제조하는 방법에 관한 것이다. 본 발명에 따른 카바폐넴계 항생제 중간체 제조 방법은 반응 용매를 바꿈으로써 로듐촉매의 활성을 높이고, 반응속도를 빠르게 할 뿐만 아니라 고가의 로듐 촉매의 사용량을 줄일 수 있어, 산업적인 측면에서 매우 경제적이고 유용하다. The present invention relates to a method for preparing a bicyclic keto ester compound, which is a key intermediate of carbapenem antibiotics. The method for preparing the carbapenem antibiotic antibiotic intermediate according to the present invention can increase the activity of the rhodium catalyst, change the reaction rate, and reduce the amount of the expensive rhodium catalyst by changing the reaction solvent, which is very economical and useful from an industrial point of view. Do.

다이아조 화합물, 비사이클릭 케토에스테르 화합물 로듐 촉매, 용매, 페넴계 항생제, Diazo compounds, acyclic ketoester compounds, rhodium catalysts, solvents, penem antibiotics,

Description

페넴계 항생제 중간체의 제조 방법{Method of preparing intermediates of penem antibiotics}Method of preparing intermediates of penem antibiotics {Method of preparing intermediates of penem antibiotics}

본 발명은 카바폐넴계 항생제의 핵심 중간체인 비사이클릭 케토에스테르 화합물(bicyclic keto ester)을 제조하는 방법에 관한 것이다. The present invention relates to a method for preparing a bicyclic keto ester compound, which is a key intermediate of carbapenem antibiotics.

페넴 중간체인 다이아조(diazo) 화합물에서 로듐 촉매를 사용하여 비사이클릭 케토 에스테르 화합물(bicyclic keto ester)을 제조하는 반응이 알려져 있다. Reactions are known for producing bicyclic keto esters using rhodium catalysts in diazo compounds, which are penem intermediates.

[반응식 1]Scheme 1

Figure 112007080995855-PAT00001
Figure 112007080995855-PAT00001

상기 화학식 1, 화학식 2 그리고 반응식 1에서, R은 카르복실산의 보호기로서, C1-4 알케닐, 또는 파라 니트로기, 파라 C1-4 알콕시기 또는 파라 C1-6 알킬기가 치환된 벤질기이고; R1는 수소, 임의로 치환된 알킬, 임의로 치환된 아릴, 임의로 치환된 헤테로시클릴기이며; R2는 수소, 아실기, 또는 알코올의 보호기로 알킬기와 아릴기로 삼치환된 실릴기이다. In Formula 1, Formula 2 and Scheme 1, R is a protecting group of carboxylic acid, benzyl substituted with C 1-4 alkenyl, or para nitro group, para C 1-4 alkoxy group or para C 1-6 alkyl group Group; R 1 is hydrogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted heterocyclyl group; R 2 is a silyl group trisubstituted with an alkyl group and an aryl group as a protecting group for hydrogen, an acyl group or an alcohol.

Figure 112007080995855-PAT00002
Figure 112007080995855-PAT00002

상기 식에서, X는 산소원자 또는 알킬기가 치환된 질소원자이며, R1, R2, R3는 수소원자, C1 ~ C30의 알킬기, 또는 불소 치환된 알킬기이다. In the above formula, X is a nitrogen atom substituted with an oxygen atom or an alkyl group, and R1, R2 and R3 are hydrogen atoms, C 1 to C 30 alkyl groups, or fluorine substituted alkyl groups.

일반적으로, 상기 화학식 2의 다이아조(diazo) 화합물로부터 상기 화학식 3의 로듐 촉매를 사용함으로써 다이아조(diazo)가 유리되면서 로듐 카베노이드(carbenoid)형성을 통해 N-H 인서션(insertion)반응을 이루어 상기 화학식 1의 비사이클릭 케토에스테르(bicyclic keto ester)화합물을 합성하는 방법이 알려져 있다. 최소 0.1 mol% (다이아조 화합물/로듐 촉매= 1000 : 1 몰 비율)이상의 다이로듐 2가 아세테이트{dirhodium(Ⅱ) acetate}를 사용하여 에틸 아세테이트, 벤젠(benzene), 톨루엔(toluene), 테트라하이드로 퓨란(THF)등을 용매로 하여 비사이클릭 케토에스테르화합물을 합성하는 방법이 알려져있다. [D. G. Melillo, I. Shinkai, Tetrahedron lett, 1980, 21, 2783; C. P. Mak, C. Mayerl, Tetrahedron Lett, 1983, 24, 347; C. Wenteup, H. W. winter, J. Am. Chem. Soc, 1980, 102, 6161; R. W. Ratcliffe, T. N. Salzmann, Tetrahedron Lett. 1980, 21, 31] In general, by using a rhodium catalyst of Formula 3 from the diazo compound of Formula 2, the diazo is liberated and NH insertion reaction is performed through rhodium carbenoid formation. A method of synthesizing a bicyclic keto ester compound of Formula 1 is known. Ethyl acetate, benzene, toluene, tetrahydrofuran using at least 0.1 mol% (diazo compound / rhodium catalyst = 1000: 1 molar ratio) of diodium divalent acetate {dirhodium (II) acetate} A method for synthesizing bicyclic ketoester compounds using (THF) or the like is known. [D. G. Melillo, I. Shinkai, Tetrahedron lett, 1980, 21, 2783; C. P. Mak, C. Mayerl, Tetrahedron Lett, 1983, 24, 347; C. Wenteup, H. W. winter, J. Am. Chem. Soc, 1980, 102, 6161; R. W. Ratcliffe, T. N. Salzmann, Tetrahedron Lett. 1980, 21, 31]

또한, 미국특허 제 4,287,123호에서는 상기 화학식 2의 화합물 중에 R이 파 라-니트로벤질기이고, R1이 수소인 화합물을 톨루엔 유기용매 하에서 2.55 mol%(화학식 2의 화합물/로듐 촉매 = 39 : 1)의 다이로듐(II) 테트라아세테이트[Rh2(CH3COO)4]를 사용하여 80~85 ℃에서 2시간 30분 동안 교반하여, R은 파라-니트로벤질기이고, R1은 수소인 화학식 1의 화합물을 제조하였다. 하지만, 이러한 방법들은 고가의 로듐 촉매를 다량으로 사용하므로 산업적인 적용에 어려움이 있다.In addition, US Pat. No. 4,287,123 discloses 2.55 mol% of a compound of Formula 2 wherein R is a para-nitrobenzyl group and R 1 is hydrogen in a toluene organic solvent. A) dichlorodium (II) tetraacetate [Rh 2 (CH 3 COO) 4 ] at 80-85 ° C. for 2 hours 30 minutes, where R is a para-nitrobenzyl group and R 1 is hydrogen The compound of 1 was prepared. However, these methods have difficulty in industrial application because they use a large amount of expensive rhodium catalyst.

본 발명자들은 반응 용매에 따라 촉매의 활성에 의한 반응 속도가 차이가 나고 화학식 1의 수율에도 영향을 미치는 것을 발견하였다. 또한, 이로 인해 로듐 촉매 사용량을 공정과정에서 적합하게 조절 사용하여 고가의 로듐 촉매의 사용량을 줄일 수 있으며, 높은 수율의 화학식 1의 화합물을 얻을 수 있음을 알고 연구한 결과 바람직한 용매로 n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트, tert-부틸 아세테이트 또는 이들의 혼합용매 및 이들을 포함하는 다른 유기혼합용매를 사용하는 것임을 발견하고 본 발명을 완성하게 되었다. The present inventors have found that the reaction rate due to the activity of the catalyst is different depending on the reaction solvent and also affects the yield of the formula (1). In addition, it is possible to reduce the amount of expensive rhodium catalyst by appropriately adjusting the amount of rhodium catalyst used in the process and to obtain a high yield of the compound of formula 1, n-propyl acetate as a preferred solvent The present invention has been completed by discovering that isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate, tert-butyl acetate or mixed solvents thereof and other organic mixed solvents including them are used.

본 발명은 상기의 문제점을 해결하기 위해 창출된 것으로서, 본 발명의 목적은 다이아조(diazo) 화합물에서 로듐 촉매를 이용하여 비사이클릭 케토에스테르(bicyclic keto ester) 화합물을 제조하는 데 있어서, 로듐 촉매의 활성을 높여 로듐촉매의 사용량을 현저히 줄여, 목적 화합물을 경제적으로 제조하는 방법을 제 공하는 데에 있다. The present invention has been made to solve the above problems, and an object of the present invention is to prepare a bicyclic keto ester compound using a rhodium catalyst in a diazo compound. The purpose of the present invention is to provide a method for economically preparing a target compound by significantly reducing the amount of rhodium catalyst used by increasing the activity of.

또한, 본 발명의 다른 목적은 다이아조(diazo) 화합물에서 로듐 촉매를 이용하여 비사이클릭 케토에스테르(bicyclic keto ester) 화합물을 제조하는 데 있어서, 로듐 촉매의 활성을 높여 반응 속도를 향상시키는 방법을 제공하는 데에 있다. In addition, another object of the present invention to prepare a bicyclic keto ester compound using a rhodium catalyst in a diazo compound, a method for improving the reaction rate by increasing the activity of the rhodium catalyst To provide.

또한, 본 발명의 다른 목적은 다이아조(diazo) 화합물 및 비사이클릭 케토에스테르(bicyclic keto ester)화합물의 비대칭 탄소 원자들의 존재로 인해 각종 광학 이성질체의 형태로 존재할 수 있는 개선된 페넴 중간체의 제조방법을 제공하는 데에 있다. Another object of the present invention is also a method for preparing an improved penem intermediate which may exist in the form of various optical isomers due to the presence of asymmetric carbon atoms of diazo compounds and bicyclic keto ester compounds. To provide.

상기와 같은 목적을 달성하기 위하여, 본 발명에서는 반응식 1에서, 화학식 2의 다이아조(diazo) 화합물로부터 화학식 3의 촉매를 사용하여 카바페넴계 항생제의 핵심 중간체인 화학식 1의 비사이클릭 케토에스테르(bicyclic keto ester) 화합물을 제조함에 있어, 반응 용매로 n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트, tert-부틸 아세테이트 또는 이들의 혼합용매 및 이들을 포함하는 다른 유기혼합용매를 사용하는 방법을 제공한다.In order to achieve the above object, in the present invention, in the reaction scheme 1, a bicyclic ketoester of formula (I) which is a key intermediate of the carbapenem antibiotic using the catalyst of formula (3) from the diazo compound of formula (2) In preparing bicyclic keto ester) compounds, n-propyl acetate, isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate, tert-butyl acetate or mixed solvents thereof and other including them Provided is a method of using an organic mixed solvent.

본 발명에 따른, 페넴계 항생제 중간체의 제조 방법은 사용되는 로듐 촉매의 효율성을 높여 반응 속도를 향상시키고 로듐 촉매의 사용량을 현저히 줄일 수 있어 목적 생성물을 매우 경제적으로 제조할 수 있는 효과가 있다.  According to the present invention, the method for preparing the penem antibiotic antibiotic intermediate may increase the efficiency of the rhodium catalyst to be used to improve the reaction speed and significantly reduce the amount of the rhodium catalyst to be used, thereby producing the target product very economically.

본 발명은 반응식 1에서, 화학식 2의 다이아조(diazo) 화합물로부터 화학식 3의 촉매를 사용하여 카바페넴계 항생제의 핵심 중간체인 화학식 1의 비사이클릭 케토에스테르(bicyclic keto ester) 화합물을 제조함에 있어, 반응 용매로 n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트, tert-부틸 아세테이트 또는 이들의 혼합용매 및 이들을 포함하는 다른 유기혼합용매를 사용하는 방법을 제공한다.The present invention relates to the preparation of a bicyclic keto ester compound of formula 1, which is a key intermediate of the carbapenem antibiotic, using the catalyst of formula 3 from the diazo compound of formula 2 in Scheme 1 Provided is a method of using n-propyl acetate, isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate, tert-butyl acetate or mixed solvents thereof and other organic mixed solvents containing them as reaction solvents. do.

<반응식 1><Scheme 1>

Figure 112007080995855-PAT00003
Figure 112007080995855-PAT00003

상기 화학식 1, 화학식 2 그리고 반응식 1에서, R은 카르복실산의 보호기로서, C1-4 알케닐, 또는 파라 니트로기, 파라 C1-4 알콕시기 또는 파라 C1-6 알킬기가 치환된 벤질기이고; R1는 수소, 임의로 치환된 알킬, 임의로 치환된 아릴, 임의로 치환된 헤테로시클릴기이며; R2는 수소, 또는 알코올의 보호기로 알킬기와 아릴기로 삼치환된 실릴기, 아실기이다. 또한 화학식 1과 화학식 2는 비대칭 탄소 원자들의 존재로 인해서 각종 광학 이성질체의 형태로 존재할 수 있다.In Formula 1, Formula 2 and Scheme 1, R is a protecting group of carboxylic acid, benzyl substituted with C 1-4 alkenyl, or para nitro group, para C 1-4 alkoxy group or para C 1-6 alkyl group Group; R 1 is hydrogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted heterocyclyl group; R 2 is a silyl group or acyl group tri-substituted with an alkyl group and an aryl group as a protecting group for hydrogen or an alcohol. Formulas 1 and 2 may also exist in the form of various optical isomers due to the presence of asymmetric carbon atoms.

Figure 112007080995855-PAT00004
Figure 112007080995855-PAT00004

상기 식에서, X는 산소원자 또는 알킬기가 치환된 질소원자이며, R1, R2, R3는 수소원자, C1 ~ C30의 알킬기, 또는 불소 치환된 알킬기이다.In the above formula, X is a nitrogen atom substituted with an oxygen atom or an alkyl group, and R 1 , R 2 and R 3 are hydrogen atoms, C 1 to C 30 alkyl groups, or fluorine substituted alkyl groups.

본 발명에서는 반응식 1의 반응에 있어서 반응식 1-1과 1-2를 통해 각각 화학식 2-1과 2-2의 화합물로부터 화학식 1-1과 2-1의 화합물을 제조하는 반응을 선택하여 연구하였다. 본 발명은 아래의 대표적 반응식 1-1과 1-2을 통해 화학식 1-1과 1-2의 화합물로 제조하는 방법뿐만 아니라, 일반적인 반응식 1에서의 화학식 2의 화합물로부터 화학식 1의 화합물을 제조하는 방법에도 적용될 수 있다.In the present invention, in the reaction of Scheme 1, the reaction of preparing the compounds of Formulas 1-1 and 2-1 from the compounds of Formulas 2-1 and 2-2 through Schemes 1-1 and 1-2, respectively, was studied. . The present invention is to prepare a compound of formula 1 from the compound of formula 1 in general scheme 1 as well as the method of preparing the compound of formula 1-1 and 1-2 through the following schemes 1-1 and 1-2 The same may apply to the method.

<반응식 1-1><Scheme 1-1>

Figure 112007080995855-PAT00005
Figure 112007080995855-PAT00005

상기 화학식 1-1, 화학식 2-1 그리고 반응식 1-1에서, R은 카르복실산의 보호기로서, C1-4 알케닐, 또는 파라 니트로기, 파라 C1-4 알콕시기 또는 파라 C1-6 알킬기가 치환된 벤질기이다. In Formula 1-1, Formula 2-1 and Scheme 1-1, R is a protecting group of carboxylic acid, C 1-4 alkenyl, or para nitro group, para C 1-4 alkoxy group or para C 1- 6 alkyl group is a substituted benzyl group.

<반응식 1-2><Scheme 1-2>

Figure 112007080995855-PAT00006
Figure 112007080995855-PAT00006

상기 화학식 1-2, 화학식 2-2 그리고 반응식 1-2에서, R은 카르복실산의 보호기로서, C1-4 알케닐, 또는 파라 니트로기, 파라 C1-4 알콕시기 또는 파라 C1-6 알킬기가 치환된 벤질기이다.In Formula 1-2, Formula 2-2 and Scheme 1-2, R is a protecting group of carboxylic acid, C 1-4 alkenyl, or para nitro group, para C 1-4 alkoxy group or para C 1- 6 alkyl group is a substituted benzyl group.

본 발명에서는, 반응 용매를 다르게 하여 반응식 1-1과 1-2의 반응을 수행했다. 즉, R이 파라 니트로기인 화학식 2-1의 화합물과 화학식 2-1의 화합물을 각각 에틸 아세테이트는 내부 온도를 70 ~ 75 ℃; 톨루엔 , n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트, tert-부틸 아세테이트는 내부 온도를 90 ~ 100 ℃에서 화학식 3의 로듐 아세테이트 0.025 mol%(화학식 2의 화합물/로듐 촉매 = 4000:1 몰 비율)를 촉매로 사용하여 반응식 1-1과 반응식 1-2의 반응에서 교반하며 진행시키고, 반응식 1-1과 반응식 1-2의 결과를 각각 표 1과 표 2에 정리하였다.In the present invention, the reactions of Schemes 1-1 and 1-2 were carried out with different reaction solvents. That is, ethyl acetate of the compound of formula 2-1 and the compound of formula 2-1 wherein R is a para nitro group, respectively, has an internal temperature of 70 to 75 ° C .; Toluene, n-propyl acetate, isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate, tert-butyl acetate have an internal temperature of 0.025 mol% of rhodium acetate of Formula 3 at 90 to 100 ° C. Compound / rhodium catalyst = 4000: 1 molar ratio) as a catalyst and proceeded with stirring in the reactions of Schemes 1-1 and 1-2, and the results of Schemes 1-1 and 1-2 are shown in Table 1 and Table 1, respectively. Summarized in 2.

하기 표 1과 표2의 결과에 제시된 바와 같이, 로듐 촉매량을 0.025 mol% 까지 줄여 사용한 결과 n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트, tert-부틸 아세테이트는 40 ~ 60 분 만에 반응이 완결되었으나, 기존에 알려진 톨루엔, 에틸 아세테이트는 반응 시간이 24시간 이상이 지나도록 더 이상 반응이 완결이 안 되고 반응 초기 화합물이 남아 있는 것이 확인되었다. 즉, 위의 결과로 미루어 볼 때, 반응식 1을 통해 화학식 1의 화합물을 제조함에 있어서 바람직한 용매는 n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트, tert-부틸 아세테이트 또는 이들의 혼합용매 및 이들을 포함하는 다른 유기혼합용매를 사용하는 것이다. As shown in the results of Tables 1 and 2 below, the amount of the rhodium catalyst was reduced to 0.025 mol%, and the result was n-propyl acetate, isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate, tert-butyl acetate The reaction was completed in 40 to 60 minutes, but the previously known toluene and ethyl acetate were not completed any more so that the reaction time was over 24 hours, and it was confirmed that the initial compound remained. That is, in view of the above results, preferred solvents for preparing the compound of Formula 1 through Scheme 1 are n-propyl acetate, isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate, tert- Butyl acetate or mixed solvents thereof and other organic mixed solvents containing them.

이하, 본 발명을 하기 실시예 및 비교예에 의해 더욱 상세히 설명한다. 단, 하기 실시예는 본 발명의 내용을 예시하는 것일 뿐 발명의 범위가 실시 예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail by the following examples and comparative examples. However, the following examples are merely to illustrate the content of the present invention is not limited to the scope of the invention.

실시예Example

비교예 1Comparative Example 1

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 에틸 아세테이트 40 ml에 넣고, 반응온도를 70 ~ 75 ℃로 유지하면서 교반하였다. 24시간 반응시킨 후 반응액을 농축한 다음, 크로마토그래피에 의한 분리법을 통해 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산 파라-니트로벤질에스테르 2.20 g(70 %)를 수득했다. 3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of ethyl acetate, and the reaction was stirred while maintaining the temperature at 70 to 75 ° C. After reacting for 24 hours, the reaction solution was concentrated, and then separated by chromatography, (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1 as a reaction product. 2.20 g (70%) of azabicyclo [3.2.0] heptane-2-carboxylic acid para-nitrobenzylester were obtained.

비교예 2Comparative Example 2

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디 옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 톨루엔(toluene) 40 ml에 넣고, 반응온도를 90 ~ 100 ℃로 유지하면서 교반하였다. 24시간 반응시킨 후 반응액을 농축한 다음, 크로마토그래피에 의한 분리법을 통해 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산파라-니트로벤질에스테르 2.27 g(72 %)를 수득했다. 3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of toluene and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 24 hours, the reaction solution was concentrated, and then separated by chromatography, (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1 as a reaction product. 2.27 g (72%) of azabicyclo [3.2.0] heptane-2-carboxylic acid para-nitrobenzyl ester were obtained.

실시예 1Example 1

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 n-프로필 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 40 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산 파라-니트로벤질에스테르 2.9 g(92 %)를 수득했다. 3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of n-propyl acetate, and the reaction temperature was maintained at 90 to 100 ° C. After reacting for 40 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1-azabicyclo [3.2.0] heptane-2-carboxylic acid 2.9 g (92%) of para-nitrobenzylester were obtained.

실시예 2Example 2

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 이소프로필 아세테이트(isopropyl acetate) 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 40 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산 파라-니트로벤질에스테르 2.87 g(91 %)를 수득했다. 3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of isopropyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 40 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1-azabicyclo [3.2.0] heptane-2-carboxylic acid 2.87 g (91%) of para-nitrobenzylester were obtained.

실시예 3Example 3

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 n-부틸 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 40 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산 파라-니트로벤질에스테르 2.8 g(89 %)를 수득했다.3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of n-butyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 40 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1-azabicyclo [3.2.0] heptane-2-carboxylic acid 2.8 g (89%) of para-nitrobenzylester were obtained.

실시예 4Example 4

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 이소부틸 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 40 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산 파라-니트로벤질에스테르 2.83 g(90 %)를 수득했다. 3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of isobutyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 40 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1-azabicyclo [3.2.0] heptane-2-carboxylic acid 2.83 g (90%) of para-nitrobenzylester were obtained.

실시예 5Example 5

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 sec-부틸 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 40 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산 파라-니트로벤질에스테르 2.77 g(88 %)를 수득했다. 3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of rhodium (II) tetraacetate were added to 40 ml of sec-butyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 40 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1-azabicyclo [3.2.0] heptane-2-carboxylic acid 2.77 g (88%) of para-nitrobenzylester were obtained.

실시예 6Example 6

화학식 2-1의 (3RS, 4RS)-알파-다이아조-3-[1(RS)-히드록시에틸]-베타,2-디옥소-4-아제티딘부타노익산 파라-니트로벤질 에스테르 3.4 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 tert-부틸 아세테이트 40 ml에 넣 고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 40 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (5RS, 6RS)-6-[(RS)-1-히드록시에틸]-3,7-디옥소-1-아자비시클로[3.2.0]헵테인-2-카르복실산 파라-니트로벤질에스테르 2.87 g(91 %)를 수득했다. 3.4 g of (3RS, 4RS) -alpha-diazo-3- [1 (RS) -hydroxyethyl] -beta, 2-dioxo-4-azetidinebutanoic acid para-nitrobenzyl ester of formula 2-1 (9.04 mmol) and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of tert-butyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 40 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (5RS, 6RS) -6-[(RS) -1-hydroxyethyl] -3,7-dioxo-1-azabicyclo [3.2.0] heptane-2-carboxylic acid 2.87 g (91%) of para-nitrobenzylester were obtained.

[표 1] 반응식 1-1의 N-H 인서션(insertion) 반응에서 반응 용매에 따른 반응성 비교.Table 1 Comparison of reactivity according to reaction solvent in the N-H insertion reaction of Scheme 1-1.

화학식2-1의 사용량Usage of Formula 2-1 용매menstruum 로듐 촉매 사용량Rhodium Catalyst Usage 반응시간Reaction time 수율yield 비교예 1Comparative Example 1 3.4 g3.4 g 에틸 아세테이트Ethyl acetate 0.025 mol%0.025 mol% 24시간24 hours 70 %70% 비교예 2Comparative Example 2 3.4 g3.4 g 톨루엔toluene 0.025 mol%0.025 mol% 24시간24 hours 72 %72% 실시예 1Example 1 3.4 g3.4 g n-프로필 아세테이트n-propyl acetate 0.025 mol%0.025 mol% 40분40 minutes 92 %92% 실시예 2Example 2 3.4 g3.4 g 이소프로필 아세테이트Isopropyl Acetate 0.025 mol%0.025 mol% 50분50 minutes 91 %91% 실시예 3Example 3 3.4 g3.4 g n-부틸 아세테이트n-butyl acetate 0.025 mol%0.025 mol% 40분40 minutes 89 %89% 실시예 4Example 4 3.4 g3.4 g 이소부틸 아세테이트Isobutyl Acetate 0.025 mol%0.025 mol% 45분45 minutes 90 %90% 실시예 5Example 5 3.4 g3.4 g s-부틸 아세테이트s-butyl acetate 0.025 mol%0.025 mol% 50분50 minutes 88 %88% 실시예6Example 6 3.4 g3.4 g t-부틸 아세테이트t-butyl acetate 0.025 mol%0.025 mol% 60분60 minutes 91 %91%

비교예 3Comparative Example 3

화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조-3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg 에틸아세테이트 40 ml에 넣고, 반응온도를 70 ~ 75 ℃로 유지하면서 교반하였다. 24시간 이상 반응시킨 후 반응액을 농축한 다음, 크로마토그래피에 의한 분리법을 통해 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 2.33 g(71 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxopropyl of formula 2-2 3.54 g (9.04 mmol) of -2-azetidinone and 40 ml of 1 mg ethyl acetate of dilodium (II) tetraacetate were added thereto, followed by stirring while maintaining the reaction temperature at 70 to 75 ° C. After reacting for at least 24 hours, the reaction solution was concentrated, and then separated by chromatography, (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7 as a reaction product. 2.33 g (71%) of dioxo-1-azabicyclo [3.2.0.] Heptane-2-carboxylate were obtained.

비교예 4Comparative Example 4

화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조-3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 톨루엔 40 ml에 넣고, 반응온도를 90 ~ 100 ℃로 유지하면서 교반하였다. 24시간 이상 반응시킨 후 반응액을 농축한 다음, 크로마토그래피에 의한 분리법을 통해 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 2.29 g(70 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxopropyl of formula 2-2 3.54 g (9.04 mmol) of -2-azetidinone and 1 mg (0.00226 mmol) of rhodium (II) tetraacetate were added to 40 ml of toluene and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for at least 24 hours, the reaction solution was concentrated, and then separated by chromatography, (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7 as a reaction product. 2.29 g (70%) of -dioxo-1-azabicyclo [3.2.0.] Heptane-2-carboxylate were obtained.

실시예 7Example 7

화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조-3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 프로필 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 40 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체 반응생성물을 여과하였다. 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 3.01 g(92 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxopropyl of formula 2-2 3.54 g (9.04 mmol) of -2-azetidinone and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of propyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After the reaction for 40 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the resultant white solid reaction product was filtered by stirring at 0 ° C. for 2 hours. (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7-dioxo-1-azabicyclo [3.2.0.] Heptane-2-car as reaction product 3.01 g (92%) of oxylate were obtained.

실시예 8Example 8

화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조- 3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 이소프로필 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 50 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 2.95 g(90 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxopropyl of formula 2-2 3.54 g (9.04 mmol) of -2-azetidinone and 1 mg (0.00226 mmol) of rhodium (II) tetraacetate were added to 40 ml of isopropyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 50 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7-dioxo-1-azabicyclo [3.2.0.] Heptane- 2.95 g (90%) of 2-carboxylate were obtained.

실시예 9Example 9

화화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조-3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 n-부틸 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 45 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 2.98 g(91 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxo of Formula 2-2 3.54 g (9.04 mmol) of propyl-2-azetidinone and 1 mg (0.00226 mmol) of rhodium (II) tetraacetate were added to 40 ml of n-butyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 45 minutes, the reaction solution was concentrated to 6.8 ml, and then, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7-dioxo-1-azabicyclo [3.2.0.] Heptane- 2.98 g (91%) of 2-carboxylate were obtained.

실시예 10Example 10

화화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조-3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 이소부틸 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 45 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 2.78 g(85 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxo of Formula 2-2 3.54 g (9.04 mmol) of propyl-2-azetidinone and 1 mg (0.00226 mmol) of dirodium (II) tetraacetate were added to 40 ml of isobutyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 45 minutes, the reaction solution was concentrated to 6.8 ml, and then, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7-dioxo-1-azabicyclo [3.2.0.] Heptane- 2.78 g (85%) of 2-carboxylate were obtained.

실시예 11Example 11

화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조-3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 sec-부틸 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 50 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 2.92 g(89 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxopropyl of formula 2-2 3.54 g (9.04 mmol) of -2-azetidinone and 1 mg (0.00226 mmol) of rhodium (II) tetraacetate were added to 40 ml of sec-butyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 50 minutes, the reaction solution was concentrated to 6.8 ml, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7-dioxo-1-azabicyclo [3.2.0.] Heptane- 2.92 g (89%) of 2-carboxylate were obtained.

실시예 12Example 12

화학식 2-2의 (3RS, 4RS)-3-[(R)-히드록시에틸]-4-[(R)-1-메틸-3-다이아조-3-알릴옥시카르보닐-1-옥소프로필-2-아제티딘온 3.54 g(9.04 mmol)과 다이로듐(II) 테트라아세테이트 1 mg(0.00226 mmol)을 tert-부틸 아세테이트 40 ml에 넣고 반응온도를 90 ~ 100 ℃로 유지하면서 교반했다. 55 분 반응시킨 후, 반응액을 6.8 ml까지 농축한 후, 농축한 반응액에 헥산 13.6 ml와 톨루엔 13.6 ml을 넣고 0℃에 서 2시간 교반하여 생성된 하얀색 고체의 반응생성물을 여과하였다. 반응 생성물로서 반응 생성물로서 (4S,5R,6S)-6-[(1R)-히드록시에틸]-4-메틸-3,7-다이옥소-1-아자비사이클로[3.2.0.]헵테인-2-카르복실에이트 2.95 g(90 %)를 수득했다. (3RS, 4RS) -3-[(R) -hydroxyethyl] -4-[(R) -1-methyl-3-diazo-3-allyloxycarbonyl-1-oxopropyl of formula 2-2 3.54 g (9.04 mmol) of -2-azetidinone and 1 mg (0.00226 mmol) of rhodium (II) tetraacetate were added to 40 ml of tert-butyl acetate and stirred while maintaining the reaction temperature at 90 to 100 ° C. After reacting for 55 minutes, the reaction solution was concentrated to 6.8 ml, and then, 13.6 ml of hexane and 13.6 ml of toluene were added to the concentrated reaction solution, and the reaction product was filtered at 0 ° C. for 2 hours to filter the reaction product. As reaction product As reaction product (4S, 5R, 6S) -6-[(1R) -hydroxyethyl] -4-methyl-3,7-dioxo-1-azabicyclo [3.2.0.] Heptane- 2.95 g (90%) of 2-carboxylate were obtained.

[표 2] 반응식 1-2의 N-H 인서션(insertion) 반응에서 반응 용매에 따른 반응성 비교. TABLE 2 Comparison of reactivity according to reaction solvent in N-H insertion reaction of Scheme 1-2.

화학식2-2의 사용량Usage of Formula 2-2 용매menstruum 로듐 촉매 사용량Rhodium Catalyst Usage 반응시간Reaction time 수율yield 비교예 3Comparative Example 3 3.4 g3.4 g 에틸 아세테이트Ethyl acetate 0.025 mol%0.025 mol% 24시간24 hours 71 %71% 비교예 4Comparative Example 4 3.4 g3.4 g 톨루엔toluene 0.025 mol%0.025 mol% 24시간24 hours 70 %70% 실시예 7Example 7 3.4 g3.4 g n-프로필 아세테이트n-propyl acetate 0.025 mol%0.025 mol% 40분40 minutes 92 %92% 실시예 8Example 8 3.4 g3.4 g 이소프로필 아세테이트Isopropyl Acetate 0.025 mol%0.025 mol% 50분50 minutes 90 %90% 실시예 9Example 9 3.4 g3.4 g n-부틸 아세테이트n-butyl acetate 0.025 mol%0.025 mol% 45분45 minutes 91 %91% 실시예 10Example 10 3.4 g3.4 g 이소부틸 아세테이트Isobutyl Acetate 0.025 mol%0.025 mol% 45분45 minutes 85 %85% 실시예 11Example 11 3.4 g3.4 g s-부틸 아세테이트s-butyl acetate 0.025 mol%0.025 mol% 50분50 minutes 89 %89% 실시예 12Example 12 3.4 g3.4 g t-부틸 아세테이트t-butyl acetate 0.025 mol%0.025 mol% 55분55 minutes 90 %90%

본 발명에 따른 페넴 중간체의 제조방법은 고가의 로듐 촉매의 활성을 높여 로듐 촉매의 사용량을 현저히 줄여 목적 화합물을 경제적으로 제조하는 것이 가능하다. 또한 반응시간이 단축되며, 높은 수율을 지니기 때문에 페넴계 항생제 중간체를 제조하는 새로운 제조방법으로 산업적으로 유용하다.According to the method for preparing the penem intermediate according to the present invention, it is possible to economically prepare a target compound by increasing the activity of an expensive rhodium catalyst and significantly reducing the amount of rhodium catalyst used. In addition, since the reaction time is shortened and has a high yield, it is industrially useful as a new manufacturing method for preparing the penem antibiotic antibiotic intermediate.

도 1은 본 발명의 화학식 2의 다이조화합물로부터 화학식 1의 비사이클릭 케토에스테르를 합성하는 반응식을 나타낸 도면이다. 상기 화학식 1, 화학식 2에서, R은 카르복실산의 보호기로서, C1-4 알케닐, 또는 파라 니트로기, 파라 C1-4 알콕시기 또는 파라 C1-6 알킬기가 치환된 벤질기이고; R1는 수소, 임의로 치환된 알킬, 임의로 치환된 아릴, 임의로 치환된 헤테로시클릴기이며; R2는 수소, 아실기, 또는 알코올의 보호기로 알킬기와 아릴기로 삼치환된 실릴기이다.1 is a diagram showing a reaction scheme for synthesizing the bicyclic ketoester of the formula (1) from the dizo compound of formula (2) of the present invention. In Chemical Formulas 1 and 2, R is a protecting group of carboxylic acid, and a benzyl group substituted with a C 1-4 alkenyl, or a para nitro group, a para C 1-4 alkoxy group, or a para C 1-6 alkyl group; R 1 is hydrogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted heterocyclyl group; R 2 is a silyl group trisubstituted with an alkyl group and an aryl group as a protecting group for hydrogen, an acyl group or an alcohol.

도 2는 본 발명의 화학식 1의 비사이클릭 케토에스테르를 합성하기 위해 사용되는 로듐 촉매의 구조식을 나타낸 도면이다. 상기 구조식에서, X는 산소원자 또는 알킬기가 치환된 질소원자이며, R1, R2, R3는 수소원자, C1 ~ C30의 알킬기, 또는 불소 치환된 알킬기이다.2 is a diagram showing the structural formula of a rhodium catalyst used to synthesize the bicyclic ketoester of the formula (1) of the present invention. In the above structural formula, X is a nitrogen atom substituted with an oxygen atom or an alkyl group, R 1 , R 2 , R 3 is a hydrogen atom, an alkyl group of C 1 ~ C 30 , or a fluorine-substituted alkyl group.

Claims (5)

하기 반응식 1에서, 화학식 2의 화합물로부터 화학식 3의 촉매를 사용하여 화학식 1의 비사이클릭 케토에스테르(bicyclic keto ester) 화합물 및 이것의 이성질체를 제조하는 방법에 있어서, 반응 용매로서, n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트 및 tert-부틸 아세테이트로 구성된 군으로부터 선택된 하나 이상의 용매를 포함하는 유기혼합용매를 사용하여 하기 화학식 1의 화합물 및 이것의 이성질체를 제조하는 방법: In Scheme 1, a method for preparing a bicyclic keto ester compound of Formula 1 and an isomer thereof using a catalyst of Formula 3 from a compound of Formula 2 is shown as n-propyl acetate. Using the organic mixed solvent containing at least one solvent selected from the group consisting of isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate and tert-butyl acetate to the compound of formula 1 and isomers thereof How to manufacture: <반응식 1><Scheme 1>
Figure 112007080995855-PAT00007
Figure 112007080995855-PAT00007
Figure 112007080995855-PAT00008
Figure 112007080995855-PAT00008
(상기 화학식 1, 화학식 2에서, R은 카르복실산의 보호기로서, C1-4 알케닐, 또는 파라 니트로기, 파라 C1-4 알콕시기 또는 파라 C1-6 알킬기가 치환된 벤질기이 고; R1는 수소, 임의로 치환된 알킬, 임의로 치환된 아릴, 임의로 치환된 헤테로시클릴기이며; R2는 수소, 아실기, 또는 알코올의 보호기로 알킬기와 아릴기로 삼치환된 실릴기이다. 상기 화학식 3에서, X는 산소원자 또는 알킬기가 치환된 질소원자이며, R1, R2, R3는 수소원자, C1 ~ C30의 알킬기, 또는 불소 치환된 알킬기이다.)(In Formula 1, Formula 2, R is a protecting group of carboxylic acid, C 1-4 alkenyl, or a benzyl group substituted with a para nitro group, a para C 1-4 alkoxy group, or a para C 1-6 alkyl group. R 1 is hydrogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted heterocyclyl group, R 2 is a silyl group tri-substituted with an alkyl group and an aryl group with a protecting group of hydrogen, acyl group or alcohol; In 3, X is a nitrogen atom substituted with an oxygen atom or an alkyl group, and R 1 , R 2 , R 3 are hydrogen atoms, an alkyl group having 1 to 30 carbon atoms, or a fluorine-substituted alkyl group.)
제 1항에 있어서, 화학식 1과 화학식 2의 R1이 수소임을 특징으로 하는 화학식 1의 화합물 및 이것의 이성질체를 제조하는 방법. 2. The method of claim 1, wherein R 1 in Formula 1 and Formula 2 is hydrogen. 제 1항에 있어서, 화학식 1과 화학식 2의 R1이 메틸기임을 특징으로 하는 화학식 1의 화합물 및 이것의 이성질체를 제조하는 방법. The method of preparing a compound of Formula 1 and an isomer thereof, according to claim 1, wherein R 1 in Formula 1 and Formula 2 is a methyl group. 상기 반응식 1에서, 화학식 2의 화합물로부터 화학식 3의 촉매를 사용하여 화학식 1의 비사이클릭 케토에스테르(bicyclic keto ester) 화합물 및 이것의 이성질체를 제조하는 방법에 있어서, 반응 용매로서, n-프로필 아세테이트, 이소프로필 아세테이트, n-부틸 아세테이트, 이소부틸 아세테이트, sec-부틸 아세테이트 및 tert-부틸 아세테이트로 구성된 군으로부터 선택된 하나 이상의 용매를 포함하는 유기혼합용매를 사용하고 상기 화학식 3의 촉매를 0.1 mol% (화학식 2의 화합물 : 화학식 3의 화합물 = 1000 : 1 몰비율)미만으로 사용하여 화학식 1의 화합물 및 이 것의 이성질체를 제조하는 방법. In Scheme 1, a bicyclic keto ester compound of Formula 1 and an isomer thereof are prepared from a compound of Formula 2 using a catalyst of Formula 3, n-propyl acetate as a reaction solvent. , Using an organic mixed solvent comprising at least one solvent selected from the group consisting of isopropyl acetate, n-butyl acetate, isobutyl acetate, sec-butyl acetate and tert-butyl acetate and adding 0.1 mol% ( A process for preparing the compound of formula 1 and isomers thereof using less than the compound of formula 2: compound of formula 3 = 1000: 1 mole ratio). 제 1항 또는 제 4항의 방법으로 제조한 화학식 1의 화합물 및 이것의 이성질체.A compound of formula 1 prepared by the method of claim 1 or 4 and an isomer thereof.
KR1020070114994A 2007-11-12 2007-11-12 Method of preparing intermediates of penem antibiotics KR20090048899A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020070114994A KR20090048899A (en) 2007-11-12 2007-11-12 Method of preparing intermediates of penem antibiotics
PCT/KR2008/006182 WO2009064078A1 (en) 2007-11-12 2008-10-20 Method of preparing intermediates of penem antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070114994A KR20090048899A (en) 2007-11-12 2007-11-12 Method of preparing intermediates of penem antibiotics

Publications (1)

Publication Number Publication Date
KR20090048899A true KR20090048899A (en) 2009-05-15

Family

ID=40857784

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070114994A KR20090048899A (en) 2007-11-12 2007-11-12 Method of preparing intermediates of penem antibiotics

Country Status (1)

Country Link
KR (1) KR20090048899A (en)

Similar Documents

Publication Publication Date Title
EP0182213A1 (en) Carbapenem compounds and production thereof
WO2007004028A2 (en) Processes for the preparation of penems and its intermediate
TWI294426B (en) Process for the preparation of ccr-2 antagonist
KR100959027B1 (en) Method of preparing intermediates of penem antibiotics using Zinc compound as co-catalyst
KR101299162B1 (en) Method for preparing intermediates of imipenem
KR20090048899A (en) Method of preparing intermediates of penem antibiotics
JP4500814B2 (en) A novel process for producing imipenem
KR20040095198A (en) Process for producing azetidinone compounds
KR100874589B1 (en) Process for preparing penem intermediate
CA2591898A1 (en) Mutilin-derivative substituted at position 12
JP2810731B2 (en) Production method of β-lactam compound
WO2022153626A1 (en) Method for manufacturing heterocycle-containing amino acid compound
KR100967341B1 (en) Process for preparing a synthetic intermediate of carbapenems
CN101367831B (en) Midbody for preparing carbpenem antibiotics and method of preparing the same
KR100234016B1 (en) 1-beta-methyl carbapenem derivatives having heterocyclicthiols including nitrogen and preparation thereof
EP0617016A1 (en) Cyclohexene derivatives
JPH0931054A (en) Azetidinone compound and its production
KR100476672B1 (en) THIOL DERIVATIVES AND 1-β-METHYL-CARBAPENEM DERIVATIVES WITH THE SAME
JPH072762A (en) Production of cyclohexene derivative
KR100969217B1 (en) The preparaton of alkenylazetidinone intermediates for carbapenems
JPWO2003011825A1 (en) Pyrrolidine derivatives and their synthesis
US5145957A (en) Stereoselective synthesis of a chiral cis 3-beta hydrogen (3R) 4-aroyloxy azetidinone
KR100641040B1 (en) Process for preparing intermediate of imipenem
JP2012506843A (en) 1,3 imidazolidine derivatives and their use in the production of carbapenem
JP2006008641A (en) Method for producing optically active dihydropyrrole and tetrahydropyridine derivative

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application